Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma
Adjuvant temozolomide improves survival in IDH-mutant anaplastic glioma
Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery
CtDNA monitoring of ER+/HER2- breast cancer during adjuvant endocrine therapy shows promise
Vepdegestrant could extend PFS for some ESR1-mutated advanced breast cancers
Olaparib boosts chemotherapy’s impact on BRCA-mutated breast cancer
Managing gastrotoxicities for RCC treatment – Gastroenterologist's perspective
WRN inhibitor shows promise in patients with MSI and/or dMMR advanced solid tumours
Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers
A conversational artificial intelligence system enhances precision medicine and health equity
Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration
Metastasis-directed radiotherapy shows good prognosis for oligometastatic kidney cancer
Circulating tumour DNA can guide adjuvant immunotherapy for mismatch repair-deficient tumours